David J. Arthur - Nov 3, 2021 Form 4 Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Chief Executive Officer, Director
Signature
/s/Mark Rosenblum, as Attorney-in-Fac
Stock symbol
SLRX
Transactions as of
Nov 3, 2021
Transactions value $
$5,700
Form type
4
Date filed
11/5/2021, 02:58 PM
Previous filing
Aug 17, 2021
Next filing
Jan 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Award $5.7K +7.94K +7.76% $0.72 110K Nov 3, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuantto the issuer's Employee Stock Purchase Plan.